Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Liver-resident and infiltrating immune cells represent the diverse immunological landscape of the liver, comprising both permanent residents and transiently recruited populations. Resident cells, such as Kupffer cells (KCs), liver-resident Natural Killer (lrNK) cells, and Mucosal-Associated Invariant T (MAIT) cells, are crucial for maintaining immune tolerance and rapid response to gut-derived antigens (Dixon et al., 2013, Comprehensive Physiology; Robinson et al., 2016, Cellular & Molecular Immunology). Infiltrating cells, including monocyte-derived macrophages, neutrophils, and various T-cell subsets, are recruited in response to injury, infection, or malignancy, often driving the progression of chronic liver diseases (Krenkel & Tacke, 2017, Nature Reviews Immunology). This collective population is central to the pathogenesis of non-alcoholic steatohepatitis (NASH), viral hepatitis, and hepatocellular carcinoma (HCC) (Ringelhan et al., 2018, Nature Reviews Gastroenterology & Hepatology). Pharmacological intervention typically involves targeting specific receptors or signaling pathways within these cells, such as CCR2/CCR5 inhibitors to block recruitment or checkpoint inhibitors to reinvigorate exhausted T cells (Tacke, 2017, Journal of Hepatology). Understanding the spatial and functional heterogeneity of these cells is vital for developing precision therapies that can resolve inflammation without compromising systemic immunity (Heymann & Tacke, 2016, Nature Reviews Gastroenterology & Hepatology).
Modulation of immune cell recruitment, activation, or exhaustion within the hepatic microenvironment (Tacke, 2017, Journal of Hepatology; Ringelhan et al., 2018, Nature Reviews Gastroenterology & Hepatology).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver-resident and infiltrating immune cells.